Abstract
ARTS will be the first trial to compare anticoagulation with a direct oral anticoagulant (apixaban) versus no anticoagulation among patients undergoing intra-abdominal, gynecologic, or urologic surgery at sufficiently similar risk of deep vein thrombosis or pulmonary embolism and major bleeding.
Copyright © 2021. Published by Elsevier B.V.
Publication types
-
Clinical Trial Protocol
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anticoagulants* / adverse effects
-
Anticoagulants* / therapeutic use
-
Female
-
Hemorrhage / etiology
-
Humans
-
Pulmonary Embolism* / etiology
-
Pulmonary Embolism* / prevention & control
-
Surgical Procedures, Operative / adverse effects
-
Venous Thromboembolism* / etiology
-
Venous Thromboembolism* / prevention & control